粪便血红蛋白指导的息肉切除术后精准监测:四百万参与者FIT筛查研究
基于3,929,387名FIT筛查参与者,纳入89,771例息肉切除术后患者,按f-Hb浓度分层制定监测间期。f-Hb 20–49 μg/g时CRC发病率为2.2/1000人年,≥450 μg/g时升至4.0/1000人年;采用f-Hb指导的精准监测可减少9.8%结肠镜需求且不增加CRC风险。
要点
- f-Hb浓度与息肉切除术后CRC风险呈阶梯式正相关,低f-Hb可延长监测间期。
- f-Hb指导的精准监测较美国指南减少9.8%结肠镜需求,CRC风险相当。
- 该策略可在现有FIT筛查框架内优化结肠镜资源配置。
核心结论
- f-Hb指导的精准监测间期可补充现有指南策略,在保持FIT筛查获益的同时优化结肠镜资源使用。
研究设计与样本
- 2010至2015年间3,929,387人参与FIT筛查,纳入89,771名50至74岁、f-Hb≥20 μg Hb/g且息肉切除术后完成结肠镜者,随访至2018年。
- 采用加速失败时间模型估计不同f-Hb浓度的CRC风险,并按比例调整监测间期。
主要发现
- 平均随访5.5年,CRC发病率为2.8/1000人年(95%CI 2.7–3.0)。
- CRC发病率从f-Hb 20–49 μg/g的2.2/1000人年阶梯式升至≥450 μg/g的4.0/1000人年。
- 按美国监测指南分层,高风险组占49.5%,低风险组占50.5%。
- 采用f-Hb指导的精准监测较美国指南减少9.8%结肠镜需求,CRC风险相当。
关键数值与推荐
- f-Hb 20–49 μg/g者CRC发病率为2.2/1000人年,≥450 μg/g者为4.0/1000人年。
- 低风险组中低f-Hb者监测间期延长,高f-Hb者间期缩短;高风险组内亦按f-Hb调整。
临床怎么用
- 在FIT筛查项目中,可依据息肉切除术后患者的f-Hb浓度个体化调整监测间期。
- 对低f-Hb的低风险患者适当延长结肠镜监测间期,对高f-Hb者缩短间期。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Defining precision postpolypectomy surveillance intervals is essential to optimize the balance between colonoscopy resource use and colorectal cancer (CRC) risk reduction within population-based fecal immunochemical test (FIT) screening programs. We sought to develop fecal hemoglobin (f-Hb) concentration-guided surveillance intervals and integrate them into the existing surveillance framework. METHODS: Between 2010 and 2015, 3,929,387 individuals participated in FIT screening, of whom 89,771 participants aged 50 to 74 years with f-Hb ≥20 μg Hb/g and complete colonoscopy after polypectomy were enrolled and monitored through 2018 for ascertaining incident CRCs. CRC risks across different f-Hb concentrations were estimated using an accelerated failure time model, and surveillance intervals were proportionally adjusted-shortened at higher f-Hb and extended at lower levels. We compared pragmatic, precision-oriented surveillance intervals with current guidelines to evaluate the extent of colonoscopy reduction without compromising CRC risk. RESULTS: There were 89,771 postpolypectomy individuals stratified as high-risk (49.5%) and low-risk (50.5%) groups based on the United States surveillance guideline. During a mean 5.5-year follow-up, CRC incidence was 2.8/1000 person-years (95% confidence interval, 2.7-3.0), increasing stepwise from 2.2/1000 person-years at 20 to 49 μg/g to 4.0/1000 person-years at ≥450 μg/g. Hypothetical f-Hb-guided surveillance intervals were lengthened for low-risk individuals with low f-Hb and shortened for those with elevated f-Hb within both risk categories. If adopting this precision approach, colonoscopy demand could be reduced by 9.8% vs current United States guidelines, while maintaining comparable CRC risk. CONCLUSIONS: Precision surveillance intervals guided by f-Hb can complement current guideline-based strategies by optimizing colonoscopy resource use while preserving the benefits of FIT-based CRC screening programs.
引用
- Chuang MP, Hsu WF, Su CW, et al. Fecal Hemoglobin-Guided Precision Postpolypectomy Surveillance Within the Current Framework: A Four-Million-Participant Fecal Immunochemical Test-Based Screening Study. Gastroenterology. 2026. PMID: 41932453. doi:10.1053/j.gastro.2026.02.045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。